Health - Latest News Search Engine - Global and Local Breaking News

Health

Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with...

–The Study Met Primary and All Secondary Efficacy Endpoints– Statistically Significant 35% Placebo-Adjusted Reduction from Baseline in Pulmonary Vascu...

Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension

hellocare.ai Enters into Collaboration with Mayo Clinic for AI Co-Innovation Project

CLEARWATER, Fla., June 10, 2025 /PRNewswire/ -- hellocare.ai, a leading AI-assisted virtual care delivery platform transforming hospital care models a...

hellocare.ai Enters into Collaboration with Mayo Clinic for AI Co-Innovation Project

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules

$6 million upfront with up to an additional $9.8 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants CRANFO...

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

SAN JOSE, Calif., June 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on ...

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Cristcot Appoints Richard Kim as Chief Commercial Officer

Proven and Dynamic Commercial Leader Joins to Build Commercialization Strategy and Organization New Drug Application for Ulcerative Colitis on Track t...

Cristcot Appoints Richard Kim as Chief Commercial Officer

DeepCure Announces DC-15442 as Development Candidate, an Oral STAT6 Inhibitor with 100% in vivo inhibition of pSTAT6 and comparable efficacy to dupilu...

DC-15442 is a potent small molecule STAT6 inhibitor, which is not a degrader or prodrug, being advanced as a safe dupilumab-in-a-pill alternative for ...

DeepCure Announces DC-15442 as Development Candidate, an Oral STAT6 Inhibitor with 100% in vivo inhibition of pSTAT6 and comparable efficacy to dupilumab across disease models

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma an...

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

Southwest General Partners with Notable to Close Care Gaps and Redefine Patient Access

The health center will leverage Notable's AI Platform to automate highly manual processes, including registration, intake, and care gap outreach SAN M...

Southwest General Partners with Notable to Close Care Gaps and Redefine Patient Access

Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates

SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializ...

Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates

Koya Medical Opens New Dallas HQ to Power Next Phase of Growth in Vascular Health

DALLAS, June 10, 2025 /PRNewswire/ -- Koya Medical ("Koya"), a global leader in vascular health innovation, today announced the grand opening of its n...

Koya Medical Opens New Dallas HQ to Power Next Phase of Growth in Vascular Health

'There was nothing hopeless about Alice' - family on fight for truth

The family of a woman who died in mental health care speak about their fight to hold staff accountable.

'There was nothing hopeless about Alice' - family on fight for truth

Opioid, Opiate, and Fentanyl Medical Treatment Without Medication Resembles Malpractice, Claims Addiction Treatment Authority In New Book

ROSWELL, N.M., June 10, 2025 /PRNewswire/ -- Board-certified nurse practitioner and recognized authority on addiction recovery, is calling for a shift...

Opioid, Opiate, and Fentanyl Medical Treatment Without Medication Resembles Malpractice, Claims Addiction Treatment Authority In New Book

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit - TMCI

NEW YORK, June 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc."...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit - TMCI

Zenas BioPharma, Inc. Class Action: Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plain...

NEW YORK, June 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Zenas BioPharma, Inc. ("Zenas BioPharma, Inc." or the "Company...

Zenas BioPharma, Inc. Class Action: Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 - ZBIO

Fibroid Surgery Breakthrough: Why LAAM® and DualPortGYN® Are Outperforming Robotic and Open Procedures

Advanced Minimally Invasive Techniques Remove Even the Largest, Most Complex Fibroids ROCKVILLE, Md., June 10, 2025 /PRNewswire/ -- Women now have acc...

Fibroid Surgery Breakthrough: Why LAAM® and DualPortGYN® Are Outperforming Robotic and Open Procedures

International Oncology Experts Meet in Kenya to Address Regional Cancer Needs

National Comprehensive Cancer Network and African Cancer Coalition take part in American Cancer Society Global Academy Regional Workshop to improve ca...

International Oncology Experts Meet in Kenya to Address Regional Cancer Needs

World Precision Instruments and SynVivo Announce Launch of EVOM™ Chip-A Breakthrough Multiplex TEER System Enabling Real-Time Organ-on-Chip Monitoring...

SARASOTA, Fla., June 10, 2025 /PRNewswire/ -- World Precision Instruments (WPI), the global leader in transepithelial electrical resistance (TEER) tec...

World Precision Instruments and SynVivo Announce Launch of EVOM™ Chip-A Breakthrough Multiplex TEER System Enabling Real-Time Organ-on-Chip Monitoring

Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United S...

Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy

Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel Advisors - ...

NEW DELHI, June 10, 2025 /PRNewswire/ -- The Global Clinical Workflow Management Software Market size is set to experience significant growth in the c...

Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel Advisors - Leading key players (GE Healthcare, Oracle Health, Allscripts Healthcare Solutions, Siemens Healthineers, Koninklijke Philips N.V., McKesson Corporation and Others)

Internationale Onkologie-Experten treffen sich in Kenia, um die regionalen Krebsbedürfnisse zu erörtern

Das National Comprehensive Cancer Network und die African Cancer Coalition nehmen am regionalen Workshop der American Cancer Society Global Academy te...

Internationale Onkologie-Experten treffen sich in Kenia, um die regionalen Krebsbedürfnisse zu erörtern